Pharmaste Daily: October 12, 2026

Go to the current selection →

DAILY SELECTION · October 12, 2026

Question focus: Pharmacy math. Drug cards rotate across medication classes.

QUESTION OF THE DAY

Make a choice. Understand the why.

Log in with a confirmed account to save your submitted response. Multiple-response questions require the complete correct set; this is Pharmaste practice feedback, not a claim about NABP scoring.

0 of 1 answered. Your latest responses are used for your recap; you can revisit any set.

Loading your question…

Continue with pharmacy math →

DRUG OF THE DAY

atorvastatin

HMG-CoA reductase inhibitor (statin)

Before opening the card, recall one use, one safety check and one counseling point.

Reveal the drug learning card

Names and formulations

  • Lipitor: oral tablet

Can be taken once daily at any time, with or without food; treatment intensity depends on dose and clinical goal.

Common use

Lowers LDL cholesterol and is used for primary or secondary cardiovascular risk reduction in patients who meet labeled indications.

Mechanism of action

Competitively inhibits HMG-CoA reductase, reducing hepatic cholesterol synthesis and increasing hepatic LDL-receptor activity.

Important adverse effects and monitoring

  • Assess for unexplained muscle pain, tenderness, or weakness; severe myopathy and rhabdomyolysis are uncommon but serious.
  • Check liver enzymes before initiation and later when clinically indicated; stop for serious hepatic injury.
  • Monitor a lipid panel and adherence to evaluate response.

Patient counseling

  • Report severe or persistent muscle symptoms, especially with fever, malaise, or dark urine.
  • Most pregnant patients should discontinue therapy after discussing the pregnancy with the prescriber; breastfeeding is not recommended during treatment.

Interaction to recognize

With: strong CYP3A4 inhibitors and certain antivirals

Why it matters: Can raise atorvastatin exposure and increase myopathy risk.

Practical response: Check the exact interacting drug in current labeling; temporary interruption, avoidance, or an atorvastatin dose limit may be required.

Check the original sources

Selected learning points; verify current labeling for the complete prescribing information.

Featured from our existing free, reviewed collections. Revisit a concept as it returns in the rotation. Featuring a resource today does not change its original source-check date.

Browse past selections →